BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6526386)

  • 1. Neurone specific enolase and S100 protein as possible prognostic indicators in melanoma.
    Rode J; Dhillon AP
    Histopathology; 1984 Nov; 8(6):1041-52. PubMed ID: 6526386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measuring S100 protein and neurone specific enolase in melanocytic tumours using video image analysis.
    Williams RA; Rode J; Dhillon AP; Jarvis LR; Skinner JM; Jamal O
    J Clin Pathol; 1986 Oct; 39(10):1096-8. PubMed ID: 2431005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S100 protein, neurone specific enolase, and nuclear DNA content in Spitz naevus.
    Rode J; Williams RA; Jarvis LR; Dhillon AP; Jamal O
    J Pathol; 1990 May; 161(1):41-5. PubMed ID: 2370597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of staining for neurone specific enolase in benign and malignant melanocytic lesions of the skin.
    Dhillon AP; Rode J
    Diagn Histopathol; 1982; 5(3):169-74. PubMed ID: 6183082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of serum S100 in metastatic malignant melanoma.
    Guo HB; Stoffel-Wagner B; Bierwirth T; Mezger J; Klingmüller D
    Eur J Cancer; 1995 Oct; 31A(11):1898-902. PubMed ID: 8541129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical study of malignant melanoma.
    Hirano T
    Acta Pathol Jpn; 1986 May; 36(5):733-43. PubMed ID: 3526811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of serum S100 in metastatic malignant melanoma.
    Guo HB; Stoffel-Wagner B; Bierwirth T; Mezger J; Klingmüller D
    Eur J Cancer; 1995 Jun; 31A(6):924-8. PubMed ID: 7646923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical investigation of S100 and NSE in cases of traumatic brain injury and its application for survival time determination.
    Krohn M; Dreßler J; Bauer M; Schober K; Franke H; Ondruschka B
    J Neurotrauma; 2015 Apr; 32(7):430-40. PubMed ID: 25211554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S-100 and NSE as serum markers in melanoma.
    Tofani A; Cioffi RP; Sciuto R; Rea S; Festa A; Di Filippo F; Cavaliere R; Maini CL
    Acta Oncol; 1997; 36(7):761-4. PubMed ID: 9490097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysing the serum levels of tumour markers and primary tumour data in stage III melanoma patients in correlation to the extent of lymph node metastases--a prospective study in 231 patients.
    Neuss H; Koplin G; Raue W; Reetz C; Mall JW
    Acta Chir Belg; 2011; 111(4):214-8. PubMed ID: 21954736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuron-specific enolase as a prognostic factor in metastatic malignant melanoma.
    Wibe E; Hannisdal E; Paus E; Aamdal S
    Eur J Cancer; 1992; 28A(10):1692-5. PubMed ID: 1389487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of S100a, vimentin, NSE, and melan A/MART-1 in seven canine melanoma cells lines and twenty-nine retrospective cases of canine melanoma.
    Koenig A; Wojcieszyn J; Weeks BR; Modiano JF
    Vet Pathol; 2001 Jul; 38(4):427-35. PubMed ID: 11467477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of neuron specific enolase and S100 protein in evaluation of brain damage in patients resuscitated from cardiac arrest].
    Miao WL; Li HL; Wang HD; Wang J; Liu H; Ren HX; Lin HY
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Dec; 19(12):749-52. PubMed ID: 18093437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of histopathological characteristics with staining patterns in human melanoma assessed by (monoclonal) antibodies reactive on paraffin sections.
    Hagen EC; Vennegoor C; Schlingemann RO; van der Velde EA; Ruiter DJ
    Histopathology; 1986 Jul; 10(7):689-700. PubMed ID: 2427431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal profile and clinical significance of serum neuron-specific enolase and S100 in ischemic and hemorrhagic stroke.
    Brea D; Sobrino T; Blanco M; Cristobo I; Rodríguez-González R; Rodríguez-Yañez M; Moldes O; Agulla J; Leira R; Castillo J
    Clin Chem Lab Med; 2009; 47(12):1513-8. PubMed ID: 19863297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of immunohistochemical staining for neuron-specific enolase, protein gene product 9.5 and S-100 protein in neuroblastoma, Ewing's sarcoma and other round cell tumours in children.
    Carter RL; al-Sams SZ; Corbett RP; Clinton S
    Histopathology; 1990 May; 16(5):461-7. PubMed ID: 2163356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical evaluation of uveal melanocytic tumors. Expression of HMB-45, S-100 protein, and neuron-specific enolase.
    Burnier MN; McLean IW; Gamel JW
    Cancer; 1991 Aug; 68(4):809-14. PubMed ID: 1855181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical study of S-100 protein and neuron specific enolase (NSE) in melanocytes and the related tumors.
    Hachisuka H; Sakamoto F; Nomura H; Mori O; Sasai Y
    Acta Histochem; 1986; 80(2):215-23. PubMed ID: 3101377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis of conjunctival melanomas in relation to histopathological features.
    Fuchs U; Kivelä T; Liesto K; Tarkkanen A
    Br J Cancer; 1989 Feb; 59(2):261-7. PubMed ID: 2649132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoreactivity of S100 protein, alpha-1-antitrypsin, and CD68 in adult and congenital granular cell tumors.
    Filie AC; Lage JM; Azumi N
    Mod Pathol; 1996 Sep; 9(9):888-92. PubMed ID: 8878020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.